ARPA-H chief is out as Trump administration cuts health agenciesnews2025-02-14T19:26:13+00:00February 14th, 2025|Endpoints News|
Drugmakers plan Trump meeting next week amid health shakeupsnews2025-02-14T17:58:32+00:00February 14th, 2025|Endpoints News|
How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruitionnews2025-02-14T15:28:33+00:00February 14th, 2025|Endpoints News|
Updated: Moderna earnings: Losses narrow as biotech cuts costsnews2025-02-14T11:30:57+00:00February 14th, 2025|Endpoints News|
Labs fear future funding cuts with Trump administration actions in limbonews2025-02-13T20:57:49+00:00February 13th, 2025|Endpoints News|
Kennedy is confirmed by Senate as Trump’s HHS secretarynews2025-02-13T16:31:05+00:00February 13th, 2025|Endpoints News|
Roche sends experimental CNS drugs to Newleos, a new biotech backed with $93.5Mnews2025-02-13T05:00:31+00:00February 13th, 2025|Endpoints News|
NIH’s funding cut plan poses challenges for researchers despite court haltnews2025-02-12T20:39:24+00:00February 12th, 2025|Endpoints News|
Pfizer wins approval in new indication for blood cancer drug Adcetrisnews2025-02-12T18:23:41+00:00February 12th, 2025|Endpoints News|
Biogen gets $250M in Royalty Pharma deal for lupus programnews2025-02-12T11:45:46+00:00February 12th, 2025|Endpoints News|
